SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-149386
Filing Date
2021-12-14
Accepted
2021-12-14 07:02:29
Documents
14
Period of Report
2021-12-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2135356d1_8k.htm   iXBRL 8-K 24857
2 EXHIBIT 99.1 tm2135356d1_ex99-1.htm EX-99.1 14788
6 GRAPHIC tm2135356d1_ex99-1img01.jpg GRAPHIC 8632
  Complete submission text file 0001104659-21-149386.txt   229510

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kprx-20211214.xsd EX-101.SCH 3040
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kprx-20211214_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kprx-20211214_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2135356d1_8k_htm.xml XML 3719
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 211489660
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences